Tris Pharma names new vice president and general counsel
31 October 2019 -

Tris Pharma Inc, a specialty pharmaceutical company, announced yesterday that it has named Jonathan N Provoost as its new vice president and general counsel.

In the new role, Provoost is to manage all of the company's legal functions.

Provoost has more than 20 years of corporate legal experience, with most of his tenure in large and medium-sized pharmaceutical organisations. His wide range of experience within the legal profession includes management of Intellectual Property, and serving as a chief compliance officer and general counsel, general transactions, litigation and various business activities. Throughout his career he has held positions of increasing management responsibility at Ikaria, PTC Therapeutics, Kos Pharmaceuticals, Bristol-Myers Squibb and Exxon Mobil Corporation. He most recently served as general counsel for Business Development & Licensing at Mallinckrodt Pharmaceuticals.